A Library of a Large Collection of Genotypically Defined Mutants

Case ID:
C04275

C04275: A Library of a Large Collection of Genotypically Defined Mutants


Value Proposition:

Tuberculosis is a serious and lethal infectious disease that exists worldwide. There is a recognized need to understand the infectivity mechanisms used by mycobacterium to identify useful therapeutic and prophylactic targets. JHU researchers have generated a near-comprehensive library of over a thousand genotypically defined M. tuberculosis mutants. The library was made using high throughput transposon-mediated random insertion mutagenesis. This collection of mycobacterium mutants provides a vast resource of defined mutants that has not been previously available. Mutation sites have been genetically mapped and defined to provide a valuable resource for clinical, pharmaceutical and basic science research. JHU scientists have also developed custom microarrays to probe to track the presence or absence of the mutants during experimentation. Advantages:

• Availability of a large collection of mutants allows a broader selection of potentially appropriate strains and increases versatility for experimental design and therapeutic agent screens.
• Library provides an available source of many mutant M. tuberculosis organisms and eliminates extensive time and expense required to produce and characterize mutants before experimental use.
• Mutant organisms of interest do not require genetic mapping because the molecular identities have already been compiled for the entire library to reduce time from data collection to data interpretation.
• Custom DNA microarray designed for the library allows high- throughput tracking of mutants.

Technical Details:

JHU researchers have generated a library of 1,183 genotypically defined Mycobacterium tuberculosis mutants using transposon-mediated random insertion mutagenesis. The transposon used to generate the library, Himar1, has a small but defined target site allowing the disruption of nearly all open reading frames, and a genetic map of the exact mutation sites has been compiled. In addition, custom microarrays have been developed to probe for the presence or absence of each mutant.

Looking for Partners:

This library can be commercialized as a tool for drug discovery and for comparative functional genomics studies.




Patent Information:
Inventors:
Category(s):
Get custom alerts for techs in these categories/from these inventors:
For Information, Contact:
Jeanine Pennington
jpennin5@jhmi.edu
410-614-0300
Save This Technology:
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum